Baricitinib Superior to Placebo in Refractory Rheumatoid Arthritis
Findings based on patients with previous inadequate response to biologics
Guidelines Updated on Duration of Dual Antiplatelet Tx in CAD
Longer-duration tx represents trade-off between decreased risk of cardiac events, increased bleeding
Pioglitazone Linked to Increased Risk of Bladder Cancer
Duration- and dose-response associations for pioglitazone; no correlation for rosiglitazone
Genetic Factors Associated With Cannabis Dependence Identified
Genome-wide association ID'd three independent regions with single nucleotide polymorphisms
Stillbirth Less Likely for Women Receiving Trivalent Flu Vaccine
Largest relative reduction in stillbirths seen for births occurring just after influenza season
Tocilizumab Treats Rheumatoid Arthritis After Non-TNFi Failure
Better efficacy for tocilizumab versus abatacept and rituximab in patients with first non-TNFi failure
No Benefit for Longer-Term Antibiotic Tx in Lyme Disease
Longer-term antibiotic tx doesn't have additional beneficial effect on health-related quality of life
Naltrexone ER Injection Cuts Opioid Relapse Rate in Inmates
Lower rate of relapse compared with usual treatment in trial involving criminal justice offenders
FDA Approves First Tx for Disease Linked to Stem Cell Transplant
Hepatic veno-occlusive disease is rare, but fatal
Improper Prescribing Common at Hospital Discharge of Seniors
Finding among older adults discharged from cardiology, internal medicine services
